Skip to content

Applying an Artificial Intelligence System to Assist In-Hospital Short-Term Insulin Pump Intensive Therapy

Applying an Artificial Intelligence System to Assist In-Hospital Short-Term Insulin Pump Intensive Therapy

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400092136
Enrollment
Unknown
Registered
2024-11-11
Start date
2024-11-11
Completion date
Unknown
Last updated
2024-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Interventions

Experimental group:Using the E-endo system to develop and adjust the insulin pump regimen
E-endo group:Using the E-endo system to develop and adjust the insulin pump regimen
Traditional treatment group:Endocrinologists develop and adjust the insulin regimen

Sponsors

Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Hospitalized type 2 diabetes 2. Age 18-75 years 3. Insulin pump and continuous glucose monitoring after admission

Exclusion criteria

Exclusion criteria: 1. Acute diabetic complications, including diabetic ketoacidosis or hyperglycemic hyperosmolar state 2. Severe diabetic complications and comorbidities, such as serious cardiovascular or cerebrovascular diseases, renal insufficiency, or liver insufficiency 3. Pregnant or breastfeeding women 4. Unable to cooperate with insulin pump and continuous glucose monitoring 5. BMI < 18 kg/m² or BMI = 35 kg/m²

Design outcomes

Secondary

MeasureTime frame
Glycemia risk index (GRI);Time below range (TBR);Time above range (TAR);Average of glucose data;Coefficient of variation of glucose data;The difference between the doctor-approved dose and the algorithm-recommended dose in the experimental group;The number of times the doctor-recommended dose differed from the algorithm-recommended dose in the experimental group;

Primary

MeasureTime frame
Time in range (TIR);

Countries

China

Contacts

Public ContactLiang Wu

Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

335644395@qq.com+86 189 3017 4268

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026